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Abstract: Most of  thalassemic patients have with deficiency of anti-oxidants and increase of oxidative stress
and few studies have been performed on deficiency of vitamins A, E, C in these patients. In this research we
intend to study the antioxidants intake and its relationship with anemia indices in children with thalassemia.
This study is a retrospective study which was performed on the children with thalassemia in Sabzevar and
Mashhad cities. The sampling method was target-based. In this study, 85 patients with thalassemia were
examined. After taking written consent and filling the demographic questionnaire, their height and weight
were measured through the common standard methods. Then, two questionnaires of two day meal reminder
and meal frequency were completed for them (in order to determine the rate and pattern of receiving
antioxidant in the present and the past) and 5cc of blood was taken from each of them so that the blood
indices could be measured. The data gathered using statistical SPSS software and applying the correlation
coefficient, linear regression, t test, Analysis of Variance (ANOVA) the relationships were analyzed. In this
study 85 patients were studied, 48(56.5%) of whom were females and 37(43.5%) of them were males. The
average age of them is 16.97±7.02 years-old and mean BMI of them was 19.03±3.71 kg/m . The mean2
antioxidants received in these patients are vitamin A 883.35±1140.58 mcg, vitamin E 4.08±3.89 mg, vitamin
C  204.40±238.71 mg and selenium 160±120 mcg, respectively. Among these antioxidants only vitamin C
has a direct and significant correlation with hematocrit in the patients (p<0.05). In this study, between
receiving vitamin A, MCV and MCH levels in the patients with thalassemia an inverse and significant
relationship was observed.
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INTRODUCTION
Thalassemia syndromes, heterogenic group is of
heredity anemia which is created due to deficiency type
I making one or more globin chain. The thalassemia
manifestations are widespread and range from
asymptotic hypochromic and microcytosis to severe
anemias and result in intrauterine death or death during
childhood if not treated (Arzanian et al., 2005).
Iran is one of the countries in the world which has been
located on the thalassemia belt. In the Caspian sea
regions and the southern Iran, 10% of people are
carriers of thalassemia genes and in the other regions
this rate ranges from 4-8% and based on the reports by
General Department for Disease Control of the Ministry
of Health, Treatment and Medical Education, the number
of patients with major beta-thalassemia is estimated to
be 12494 people nationwide and considering the cases
not yet diagnosed or cases with mean symptoms, it has
been estimated to be around 15000 people (Hagh
Shenasi et al., 1997).
These patients are encountered with various
complications such as cardiovascular, pulmonary,
neural, psychological, ophtalmological, dermal, bilious,
joint, ENT, endocrine disorders and the cardiac
complications is one of the most prevalent and
important causes of death in these patients which
appear at the second decade of life and after
manifestation, they cause heart failure within a short
time, the workload of the heart increases due to the
hypoxia and sclerosis of the systemic vessels and the
precipitation of iron in myocardium and subsequently
results in the increase of oxidative stress and death
(Hagh Shenasi et al., 1997; Aessopos et al., 2007).
Today, different studies indicate that high levels of
oxygen together with hemoglobin containing iron
attacking the non-saturated fat acids RBC result in
producing free radicals(ROS) in the red blood cells of
the thalassemic patients which through changing red-ox
status of these patients and intensification of the
oxidative stress, the complications of these disease are
also intensified (Tesoriere et al., 2006; Cheng et al.,
2005). The antioxidant systems include super-oxide
demostasis and catalysis enzymes and the samples
containing  tioul  such  as glutathione and peroxyredoxin
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and also vitamin E are able to reduce oxidative stress 8.9% patients. 42.9% of the people were affected by
(Cheng et al., 2005). In the recent years, the role of
antioxidants on the improvement of oxidative stress and
the heart failure has been emphasized. With regard to
the fact that most diseases resulting from antioxidant
deficiency and the increase of oxidative stress and few
studies made in this respect, C, E, A deficiencies in
these people have been considered (Tesoriere et al.,
2006; Dhawan et al., 2005; Cheng et al., 2005). In this
study, we intend to investigate the status of antioxidants
received and the relationship between the anemia
indexes in the children with thalassemia.
MATERIALS AND METHODS
This study is a retrospective research which has been
performed on the thalassemic children in Sabzevar and
Mashhad cities. The sampling method is target-based.
This study has been performed on 85 subjects selected
from among the patients with thalassemia. The sample
was obtained concerning vitamin A which the most
required sample has been estimated among the
variables with type 1 error 0.05 and the test potential of
80%. The thalassemic children referred to the Vasee
Hospital and Thalassemia Hospital in Mashhad (Sarver
clinic) who have been prescribed blood transfusion and
had already done three blood transfusions during a
week and received 450 cc pack cell each time, were
selected as subjects. After taking written consent and
filling demographic questionnaire, their height and
weight was measured through standard methods. Then,
two day food reminder questionnaire and meal
frequency questionnaire were filled for them (in order to
determine the level and pattern of receiving antioxidants
in the present and the past) and 5cc blood was taken
from them for measuring the blood indices.
Data collection instruments in this study include
questionnaire and laboratorial checklist. For
determination of reliability of the researcher-made
questionnaires, content validity and equivalent reliability
were used for evaluating the credibility of the research.
The questionnaire and lab check lists were assessed by
two university professors. The lab methods and food
process application are also standard.
The data gathered with the SPSS software and through
correlation coefficient, linear regression, t test, ANOVA
(for eliminating confounding variables) were analyzed.
RESULTS 
In this study, 85 patients were examined [48 (56.5%)
were females and 37 (43.5%) were males]. The average
age of the patients was 16.97±02 and their average BMI
was 19.03±3.71 kg/m . Among these patients 47.8%2
had family background with thalassemia and 52.2% did
not have any history of this disease. 86.1% of them were
with minor and 5.1% were with major type and both
types of thalassemia were seen in the family history of
splenomegaly after being affected with thalassemia,
30.7% of them were splenectomized. The average
antioxidants received and the hematological indices of
the patients and their relationship with one another are
presented in the Table 1, 2 and 3, respectively.
Table 1: Mean±SD of antioxidants intake in thalassemic patients
Antioxidant Mean±SD
Vitamin A (mcg) 883.35±1140.58
Vitamin E (mg) 4.08±3.89
Vitamin C (mg) 204.40±238.71
Selenium (mcg) 160±120
Table 2: Mean±SD of blood indices in thalassemic patients
Blood indices Mean±SD
Hemoglobin 9.72±1.70
Hematocrit 28.61±3.08
Ferritin 3147.94±1855
MCV 80.70±4.83
MCH 26.90±1.95
MCHC 33.54±4.58
RBC 3.51±0.35
DISCUSSION
In this study, the average antioxidants received excluding
vitamin C is lower than the standard amounts in the
thalassemic patients. Only vitamin C is about three
times more than the amount received. Claster et al.
(2009) indicated that 40-75% of the patients with
thalassemia are with antioxidant deficiencies such as
vitamins A and C and Selenium (Claster et al., 2009).
In the study made by Livrea, in the thalassemic patients
as compared with healthy people, the vitamin C rate of
serum was 44%, vitamin E of serum was 42%, vitamin
A of serum was 44%, Beta carotene of serum was 29%
and lycopen of serum was 67% lower. He believes that
the low level of vitamins E and A in serum of these
patients is due to the disorder in the liver function,
increase of oxidative processes and receiving low
amount of foods rich in these vitamins (Livrea et al.,
1996).
Therefore, the results of this study are supported by Ali
et al. (2003). In the study which was performed on 63
patients who were 2-18 year old with thalassemia and
62 healthy subjects, the vitamin E, selenium and zinc in
the serum in the people with thalassemia were lower
than the control group (Ali et al., 2003).
Livrea et al. (1998) studied that 35 patients with
thalassemia between 10-60 years of age indicated that
the vitamin E level and beta-carotene in the LDL-C of
these patients are 45 and 24%, respectively. In the
healthy people, it is somewhat correspondent with the
results  of  our  study.  In  addition,  in  his study, oxidized
LDL-C of patients with thalassemia are triple and the
MDA level of them is double than the healthy people
which represents an increase in the oxidative stress in
these patients (Livrea et al., 1998).
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Table 3: Correlation between antioxidants and blood indices in thalassemic patients
Hb Hct Ferritin MCV MCH MCHC
Vitamin A (mcg) NS NS NS P = 0/001 P = 0/01 NS
R = -0/36 R = -0/28
Vitamin E (mg) NS NS NS NS NS NS
Vitamin C (mg) NS P = 0/007 NS NS P = 0/02
R = 0/3 R = 0/25 NS
Selenium (mcg) NS NS NS NS NS NS
Table 4: Mean±SD of energy and nutrients intake in thalassemic
patients
Energy and nutrients Mean±SD
Energy 2397.61±1065.23
Carbohydrate 335.13±136.60
Protein 92.01±57.93
SAFA 23.64±15.60
MUFA 28.56±15.45
PUFA 18.21±9.81
Calcium 1271.64±1271.54
Phosphor 1200.98±743.66
Sodium 1143.33±771.57
Potassium 2681.45±1784.56
Iron 26.10±11.15
Zinc 10.06±7.03
Also, the study made by Dissagabutra (2005) indicated
that vitamins C and E levels, glutathione and the Total
Antioxidant Content (TAS) in these patients were low.
This supports our results about the deficit in vitamin E
and contradicts with our results about receiving the
vitamin A (Dissagabutra et al., 2005). As you can see in
the findings of this study, the hematocrit and hemoglobin
levels of the serum are lower than the normal and the
ferritin of serum is higher than normal. Dissagabutra
believes that the low level of hemoglobin in the blood is
due to the over-hemolysis of the red blood cells because
of synthesis of un-natural hemoglobin and on the other
hand due to the increase of producing free radicals such
as peroxide hydrogen and destruction of the cell
membranes, RBCs (Dissagabutra et al., 2005).
Lisboa believes that by inhibiting the destruction of red
blood cells, antioxidants are protectors of RBCs and
prevent from their hemolysis. In his study performed on
24 thalassemic patients (18 patients with major
thalassemia and 18 with thalassemia sickle badge),
receiving daily 500-1000 mg vitamin E during one year,
then reducing lipid peroxidation and MDA in Red Blood
Cells, the half life of the RBCs were increased and the
average of annual hemoglobin increased (from 10.52-
11.96 gr/deciliter) (Costa, 1986).
Livrea believes that production of free radicals by ferritin
of serum has a direct relationship and in his study, he
has demonstrated that the concentration of vitamin A of
the serum has an inverse relationship with ferritin and
the production of free radicals (Livrea et al., 1996). In our
study, due to the low intake level, no relationship was
observed. In Cay and Naziroglu, (1999) also receiving
antioxidants such as vitamin A and Selenium for five
consecutive weeks by the mice could not change
hematological indices: MCV, MCH, MCHC as compared
with control group (Cay and Naziroglu, 1999). 
In our study, there is a significant and direct relationship
only between receiving vitamin C and hematocrit which
can be due to the high reception of vitamin C by the
patients. The Chen et al. (2000) results support our
results, these researchers stated that overload of iron in
the presence of vitamin C reduces oxidative stress and
the production of iso-prostan F2 and vitamin C deficit
creates pathologic changes especially as increasing
triglycerides of the serum and oxidized products are
increased (Chen et al., 2000). Gerster indicated that
reception of vitamin C has been useful for thalassemic
patients and has adversely affected incurrence of heart
disease (Gerster, 1999). Dissagabutra states:
"Combined consumption of vitamins E and C has
promoted the antioxidant status of the thalassemic
patients and has improved their liver function in them
and bilirubin of the serum has been reduced
(Dissagabutra et al., 2005).
Furthermore, in this study between receiving vitamin A,
MCV and MCH levels, an inverse and significant
relationship was observed. Up to the present time, no
studies have been made on the effect of the vitamin A on
the MCV indexes (average globulin volume) and MCH
(mean hemoglobin cells) so that we can compare our
findings with them. But Bazuaye has suggested that
between the reception of vitamin A and anemia
megaloblastic in which MCV increases, there is an
inverse relationship (Bazuaye et al., 2005). Ozdem et al.
(2008) showed that patients with acid folic and B12
vitamins deficit are affected with degrees of
megaloblastic anemia (Ozdem et al., 2008). In our study,
reception of vitamin A was at the borderline and such a
relationship was observed. Katerels believes that low
amount of vitamin A and protein carrying (RBP) in the
thalassemic patients can be the cause for the abnormal
performance of liver in these patients (Katerelos et al.,
1979).
Conclusion: The results of this study indicate that there
is deficiency in receiving total antioxidants excluding
vitamin C in the patients with thalassemia and regarding
the benefits of these micronutrients for these patients,
the necessity of consuming vegetables and fruits which
are replete with antioxidants is recommended.
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